---
title: "21 CFR Part 11 explained: electronic records rules | Quantlix"
description: "21 CFR Part 11 sets FDA rules for trustworthy electronic records and signatures. Learn what it requires, how FDA applies it today and what it means for software."
canonical: "https://quantlix.com/en/standards/21-cfr-part-11/"
last-updated: 2026-11-16
---

Source: https://quantlix.com/en/standards/21-cfr-part-11/
Language: en
Description: 21 CFR Part 11 sets FDA rules for trustworthy electronic records and signatures. Learn what it requires, how FDA applies it today and what it means for software.

**21 CFR Part 11** [Quality and regulated operations](https://quantlix.com/en/standards/#quality)

# 21 CFR Part 11: FDA rules for electronic records and signatures

21 CFR Part 11 is the FDA regulation that sets the conditions under which electronic records and electronic signatures are trusted as equivalent to paper records and handwritten signatures.

[Discuss your project](https://quantlix.com/en/contact/) [Read the key points](https://quantlix.com/en/standards/21-cfr-part-11/#standard-overview)

## At a glance

**Full name**

Title 21 Code of Federal Regulations, Part 11: Electronic Records; Electronic Signatures

**Published by**

US Food and Drug Administration (FDA)

**Type**

Federal regulation

**Current version**

Published March 20, 1997 and effective August 20, 1997, with later scope amendments; FDA's September 2003 scope and application guidance still shapes enforcement

**Applies to**

Records required by FDA regulations, or submitted to FDA, that are created, kept or signed electronically

**Last reviewed**

November 16, 2026 (2026-11-16)

## In plain terms

### Key points

- Part 11 applies when records required by other FDA regulations, the predicate rules, are kept or signed electronically.
- For closed systems it calls for validation, accurate copies, record protection, access limits, audit trails and authority checks, among other controls.
- An electronic signature must be unique to one person, show the name, date, time and meaning, and be linked to the record it signs.
- Since 2003, FDA has used enforcement discretion for validation, audit trail, retention and copy requirements, guided by risk and the predicate rules.
- For clinical research, FDA finalized a questions and answers guidance on electronic systems, records and signatures in October 2024.

### What is 21 CFR Part 11?

21 CFR Part 11 is **the FDA regulation for electronic records and electronic signatures**. It sets the criteria under which FDA considers electronic records, and the signatures applied to them, to be trustworthy, reliable and generally equivalent to paper records and handwritten signatures.

FDA published it in March 1997 so regulated companies could move from paper to computer systems without losing the integrity regulators depend on. Part 11 does not say which records you must keep. Those requirements come from other FDA regulations, known as predicate rules, such as good manufacturing practice for drugs or the rules for clinical investigations. Part 11 applies when those records are kept or signed electronically.

### What it requires

- **System validation.** Systems are validated to show accuracy, reliability, consistent intended performance and the ability to detect invalid or altered records.
- **Audit trails.** Secure, computer-generated, time-stamped audit trails record who created, changed or deleted a record and when, without obscuring earlier values, and are kept as long as the records themselves.
- **Access and checks.** Access is limited to authorized people, and authority, operational and device checks control who can sign, alter records or perform each step in sequence.
- **Records and copies.** Records stay retrievable for their full retention period, and accurate, complete copies can be produced in human-readable and electronic form for inspection.
- **Electronic signatures.** Each signature is unique to one person, shows the printed name, date, time and meaning (such as review or approval) and is linked to its record so it cannot be copied to another. Signatures not based on biometrics use at least two components, such as an ID and a password, and organizations certify to FDA that their electronic signatures are legally binding.
- **People and procedures.** Staff who build, maintain or use the system are trained, written policies hold signers accountable and system documentation is under change control.

### How FDA applies it today

FDA’s **2003 guidance on scope and application** changed how the rule works in practice. FDA said it would use enforcement discretion for the specific Part 11 requirements on validation, audit trails, record retention and record copying, and for legacy systems in use before August 20, 1997 that meet set conditions. The predicate rules still apply, and FDA said it would keep enforcing the other provisions, such as access limits and signature controls. The result is a risk-based approach: the depth of validation and audit trail control follows the impact a record has on product quality, safety and data integrity.

For clinical research, FDA finalized a questions and answers guidance on electronic systems, records and signatures in clinical investigations in October 2024, written for sponsors, investigators, ethics boards and contract research organizations. Some food records sit outside Part 11 by rule, for example records kept only to meet the [FSMA 204](https://quantlix.com/en/standards/fsma-204/) food traceability rule.

### How it shows up in software projects

- **Audit trail design.** The system captures every create, change and delete with user, timestamp, old and new values and a reason where the process needs one, and users cannot edit or switch it off.
- **Signature workflows.** Signing screens show the meaning of the signature, re-authenticate the user and bind the signature to a specific record version.
- **Identity and access.** Unique accounts, role-based permissions, password and session rules and periodic access reviews, often through the company identity provider.
- **Validation evidence.** Requirements, risk assessment and traceable test evidence kept current as releases ship, often following [GAMP 5](https://quantlix.com/en/standards/gamp-5/).
- **Retention and export.** Records and audit trails stay readable and exportable for the full retention period, including after a system is retired.

### How we work with 21 CFR Part 11

We build and modernize software for regulated [life sciences](https://quantlix.com/en/industries/life-sciences/) teams, including laboratory, quality and clinical systems, with Part 11 controls designed in from the first sprint: audit trails, signature workflows, access control and validation documentation your quality team can review. Where you also manufacture for Europe, we align the same controls with [EU GMP Annex 11](https://quantlix.com/en/standards/eu-gmp-annex-11/).

Validation and compliance are your organization’s responsibility, assessed by your quality unit and, ultimately, by FDA. Our part is to deliver systems and evidence that make that assessment straightforward. Our [enterprise applications](https://quantlix.com/en/services/enterprise-applications/) page describes how we run these projects.

## Where it applies

Industries where this standard often shapes the work.

- ### [Pharmaceuticals & Life Sciences](https://quantlix.com/en/industries/life-sciences/)

  Research data, pharmaceutical operations and biotechnology platforms

## Related standards

[All standards](https://quantlix.com/en/standards/)

- EU GMP Annex 11

  ### [EU rules for GMP computer systems](https://quantlix.com/en/standards/eu-gmp-annex-11/)

  EU GMP Annex 11 is the European guideline for computerized systems used in GMP-regulated activities, covering risk management, suppliers, validation, data integrity, security and day-to-day operation.
- GAMP 5

  ### [Risk-based GxP system validation](https://quantlix.com/en/standards/gamp-5/)

  GAMP 5 is the ISPE industry guide to a risk-based approach to compliant GxP computerized systems, used to plan specification, verification and lifecycle control for regulated software.
- ICH E6

  ### [Good clinical practice for trials](https://quantlix.com/en/standards/ich-e6/)

  ICH E6 is the international guideline for good clinical practice (GCP), the ethical and quality standard for designing, running, recording and reporting clinical trials of medicines. E6(R3) is the current revision.

## Services that support this work

The services we usually bring to projects that involve this standard.

[View all services](https://quantlix.com/en/services/)

### [Enterprise applications](https://quantlix.com/en/services/enterprise-applications/)

Quantlix designs and builds enterprise applications for internal workflows, business rules and system integration, with clear access controls and maintainable architecture.

### [Cloud architecture](https://quantlix.com/en/services/cloud-architecture/)

Quantlix designs cloud infrastructure around workload requirements, security boundaries, operational visibility and cost, with an explicit path for deployment and recovery.

### [DevOps engineering](https://quantlix.com/en/services/devops-engineering/)

Quantlix develops delivery pipelines, infrastructure automation and observability so teams can release software through repeatable, reviewable operational processes.

## Questions, answered

What teams usually ask us about this standard.

**Who needs to comply with 21 CFR Part 11?**

Any organization that keeps records required by FDA regulations in electronic form, submits electronic records to FDA or signs those records electronically. That includes drug, biologic and device manufacturers, clinical trial sponsors and investigators, laboratories and the contract organizations that work for them.

**Is there such a thing as Part 11 certified software?**

No. FDA does not certify software. Compliance depends on how a system is validated, configured and used within your procedures, so a vendor can supply features and documentation that support Part 11 while the regulated company remains responsible.

**Does the 2003 guidance mean Part 11 is no longer enforced?**

No. The 2003 guidance narrowed FDA's reading of the scope and announced enforcement discretion for some requirements, such as validation and audit trails, but the rule remains in effect and the predicate rules apply in full. FDA said it would keep enforcing other controls, such as limiting system access and the electronic signature requirements.

**How does Part 11 differ from EU GMP Annex 11?**

Part 11 is a binding US regulation focused on electronic records and signatures across FDA-regulated activities. EU GMP Annex 11 is a European guideline for computerized systems in medicine manufacturing, with more on risk management, suppliers and the system lifecycle. Many companies design one set of controls that meets both.

**Does Part 11 apply to cloud and SaaS systems?**

Yes, when they hold records required by FDA rules. Hosting does not move responsibility: the regulated company still needs validation evidence, access controls, audit trails and agreements with the provider that cover those records.

## Official sources

Read the official text before relying on any detail. What applies to you depends on your role, your location and the version in force.

- [21 CFR Part 11 on eCFR](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11)
- [FDA guidance: Part 11 scope and application (2003)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application)
- [FDA guidance: electronic systems in clinical investigations (2024)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/electronic-systems-electronic-records-and-electronic-signatures-clinical-investigations-questions)

These guides explain each standard in plain terms. They are not legal advice, and they do not state that any product or organization conforms to a standard.

## Planning software around this standard?

Tell us which systems are involved and what you need to show. We will help you build the requirements in from the start.

[Discuss your project](https://quantlix.com/en/contact/)
